Bristol-Myers Squibb Company | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (117)

View All

Latest Posts

About This Stock More About This Stock
Be A Smart Investor – Don’t Hold On For Dear Life
Article By: Paul Schatz
Wednesday, March 13, 2024 12:39 PM EDT
You have to give credit where it’s due. The bulls have been relentless for almost 18 months, but certainly over the past 5 months.
In this article: BMY, PFE, SPY
Read
A Look At Pharma ETFs After Q4 Earnings
Article By: Sweta Killa
Monday, February 12, 2024 6:40 PM EDT
The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth.
In this article: BMY, JNJ, LLY, MRK, PFE, IHE, PJP, PPH, XPH, FTXH
Read
What To Do With High-Flying Tech At The Start Of 2024?
Article By: Claus Vistesen
Saturday, December 23, 2023 7:20 AM EDT
Here, I will do two things. First, I will look at the macro backdrop at the start of 2024, and secondly I will run through the portfolio, how it is doing, and what changes I have made, or intend to make, to beat my investments into shape for 2024.
In this article: SPX Also: BMY, JNJ, AAPL, ADBE, MSFT, NDX
Read
Week In Review: SystImmune Out-Licenses Global Rights For ADC To BMS In $8.4 Billion Deal
Article By: ChinaBio® Today
Saturday, December 16, 2023 3:16 PM EDT
SystImmune, the Seattle arm of Chengdu’s Biokin Pharma, out-licensed global rights (ex-China) for a bispecific ADC to Bristol Myers Squibb in a $8.4 billion agreement.
In this article: BMY, CNTB
Read
Week In Review: Hansoh Sells Ex-China ADC Rights To GSK In $1.6 Billion Deal
Article By: ChinaBio® Today
Saturday, October 28, 2023 2:40 PM EDT
Hansoh Pharma sold ex-China rights for its B7-H4 ADC to GSK in a $1.57 billion deal. Meanwhile, OrbiMed has raised $4.3 billion in commitments for three healthcare funds, including $751 million for its OrbiMed Asia V fund.
In this article: GSK, LIAN, OCEA Also: BMY, MRK
Read
All Posts

Latest Tweets for $BMY

No tweets yet!

PARTNER HEADLINES

$BMY

Comments Status Updates
Macy’s Q1 Was Bad, But The Company Has The Cash To Survive The Current Pandemic
Jonathan Weber • 7/3/2020 4:06:07 PM

Glad you liked it Sheryl! Right now I think a range of REITs and healthcare stocks are attractive from a risk-reward standpoint, including $ABBV, $BMY, $O, $SLG, $SPG, etc.

Bristol-Meyers (BMY) Head And Shoulders Pattern
Flat Broke • 2/26/2020 8:46:50 PM

I fear bad news is acoming for $BMY.

Bristol-Myers To Buy Celgene; A $74 Billion Deal
Kalara J. Curtis • 5/22/2019 10:47:49 AM

Nice info, thanks for sharing with us. Bullish on $BMY

OncoSec Raising Its Profile In Fight Against Cancer
Dick Kaplan • 9/6/2017 4:03:09 PM

Very impressed with the #OncosSec trial results. $ONCS $MRK $BMY

1 to 4 of 4 comments